Guggenheim Transfers Coverage on Revance Therapeutic (RVNC), Upgrades to Buy
Tweet Send to a Friend
Guggenheim analyst Seamus Fernandez assumes coverage on Revance Therapeutic (NASDAQ: RVNC) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE